References
1. Peters RL, Allen KJ, Dharmage SC, et al. Natural history of peanut allergy and predictors of resolution in the first 4 years of life: A population-based assessment. J Allergy Clin Immunol 2015;135:1257–1266 e1-2.
2. Graham F, Caubet JC, Eigenmann PA. Can my child with IgE-mediated peanut allergy introduce foods labeled with “may contain traces”? Pediatr Allergy Immunol 2020;6:601-607.
3. Yanagida N, Okada Y, Sato S, Ebisawa M. New approach for food allergy management using low-dose oral food challenges and low-dose oral immunotherapies. Allergol Int. 2016;65:135-140.
4. Simons FER, Ardusso LRF, Bilò MB, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 2011;4:13-37.
5. Ebisawa M, Ito K, Fujisawa T. Japanese guidelines for food allergy 2020. Allergol Int 2020;69:370-386.
6. Midun E, Radulovic S, Brough H, Caubet J.C Recent advances in the management of nut allergy. World Allergy Organ J 2021;14:100491.
7. Arkwright PD, MacMahon J, Koplin J, et al. Severity and threshold of peanut reactivity during hospital-based open oral food challenges: An international multicenter survey. Pediatr Allergy Immunol 2018;29:754-761.
8. Reier-Nilsen T, Michelsen MM, Lødrup Carlsen KC, et al. Predicting reactivity threshold in children with anaphylaxis to peanut. Clin Exp Allergy 2018 Apr; 48:415-423.
9. Nagakura KI, Yanagida N, Sato S, et al. Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan. Pediatr Allergy Immunol 2018;29:512-518.
10. Nagakura KI, Yanagida N, Miura Y, et al. Long-term follow-up of fixed low-dose oral immunotherapy for children with wheat-induced anaphylaxis. J Allergy Clin Immunol Pract 2021;7:1117-1119.e2.